HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Esteban Celis Selected Research

montanide ISA 51

7/2007Overlapping human leukocyte antigen class I/II binding peptide vaccine for the treatment of patients with stage IV melanoma: evidence of systemic immune dysfunction.
8/2006Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Esteban Celis Research Topics

Disease

97Neoplasms (Cancer)
12/2021 - 03/2002
22Melanoma (Melanoma, Malignant)
01/2018 - 06/2005
8Breast Neoplasms (Breast Cancer)
06/2017 - 05/2005
7Experimental Melanoma
01/2017 - 06/2003
7Carcinoma (Carcinomatosis)
11/2015 - 10/2002
6Squamous Cell Carcinoma of Head and Neck
12/2020 - 12/2012
5Prostatic Neoplasms (Prostate Cancer)
11/2020 - 10/2002
5Lymphoma (Lymphomas)
07/2017 - 10/2004
5T-Cell Lymphoma (Lymphoma, T Cell)
02/2015 - 10/2004
4Leukemia
07/2021 - 07/2006
4Infections
01/2020 - 12/2012
3Neoplasm Metastasis (Metastasis)
01/2019 - 06/2009
3Colonic Neoplasms (Colon Cancer)
06/2017 - 03/2007
3Virus Diseases (Viral Diseases)
02/2017 - 08/2015
3Hematologic Neoplasms (Hematological Malignancy)
06/2015 - 04/2008
3T-Cell Leukemia (Leukemia, T Cell)
12/2012 - 10/2004
2Bites and Stings (Sting)
06/2017 - 08/2015
2Lung Neoplasms (Lung Cancer)
06/2013 - 11/2011
2Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
12/2012 - 10/2004
2Multiple Myeloma
11/2012 - 07/2010
2Graft vs Host Disease (Graft-Versus-Host Disease)
12/2009 - 02/2002
2Ewing Sarcoma (Sarcoma, Ewing)
07/2006 - 06/2005
1Head and Neck Neoplasms (Head and Neck Cancer)
12/2021
1Testicular Neoplasms (Testicular Cancer)
12/2020
1Osteonecrosis (Kienbock's Disease)
01/2020
1Squamous Cell Neoplasms (Squamous Cell Cancer)
01/2018
1Liver Neoplasms (Liver Cancer)
01/2018
1Hepatocellular Carcinoma (Hepatoma)
01/2018

Drug/Important Bio-Agent (IBA)

53Peptides (Polypeptides)IBA
12/2021 - 04/2002
52AntigensIBA
12/2021 - 03/2002
37VaccinesIBA
12/2021 - 03/2002
31EpitopesIBA
12/2021 - 04/2002
15Proteins (Proteins, Gene)FDA Link
07/2021 - 10/2002
15Protein Subunit VaccinesIBA
03/2019 - 04/2002
13T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA
12/2021 - 10/2004
12CytokinesIBA
01/2020 - 03/2010
8Neoplasm Antigens (Tumor Antigens)IBA
12/2021 - 04/2002
7Cancer VaccinesIBA
12/2021 - 04/2002
7LigandsIBA
06/2017 - 09/2007
7AntibodiesIBA
11/2015 - 06/2003
5HLA-DR Antigens (HLA-DR)IBA
12/2021 - 09/2014
5Therapeutic UsesIBA
11/2015 - 12/2009
5AutoantigensIBA
03/2012 - 10/2004
5Toll-Like Receptor AgonistsIBA
07/2010 - 09/2005
5HLA-A2 Antigen (HLA A2 Antigen)IBA
02/2009 - 10/2002
5Carcinoembryonic AntigenIBA
02/2009 - 07/2002
4ChemokinesIBA
01/2020 - 06/2013
4LipidsIBA
12/2017 - 08/2010
3HLA Antigens (Human Leukocyte Antigens)IBA
12/2020 - 06/2007
3Immune Checkpoint InhibitorsIBA
01/2020 - 08/2017
3Interferon Type IIBA
01/2020 - 08/2015
3B7-H1 AntigenIBA
01/2019 - 03/2014
3Interleukin-2 (IL2)IBA
01/2018 - 04/2012
3InterferonsIBA
01/2018 - 01/2011
3DNA (Deoxyribonucleic Acid)IBA
06/2016 - 11/2008
3HLA-DR15 antigenIBA
12/2012 - 10/2004
3Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
03/2010 - 08/2006
3CPG-oligonucleotideIBA
02/2009 - 06/2003
2Granzymes (Granzyme)IBA
12/2021 - 10/2012
2nutlin 3IBA
12/2021 - 01/2017
2Double-Stranded RNA (RNA, Double Stranded)IBA
11/2020 - 01/2020
2Lysine (L-Lysine)FDA Link
01/2020 - 05/2014
2poly ICLCIBA
01/2020 - 01/2018
2Monoclonal AntibodiesIBA
01/2019 - 03/2014
2Differentiation AntigensIBA
01/2018 - 08/2006
2bis(3',5')-cyclic diguanylic acidIBA
06/2017 - 08/2015
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2017 - 03/2010
2Complementary DNA (cDNA)IBA
05/2015 - 10/2012
2Transforming Growth Factor beta (TGF-beta)IBA
09/2014 - 04/2008
2Histocompatibility Antigens Class IIIBA
05/2014 - 07/2006
2Subunit VaccinesIBA
04/2013 - 04/2002
2HLA-DR53IBA
12/2012 - 05/2005
2FurinIBA
12/2012 - 04/2004
2PerforinIBA
10/2012 - 04/2010
2Interferon-gamma (Interferon, gamma)IBA
08/2012 - 04/2008
2DNA VaccinesIBA
03/2012 - 11/2008
2Immunologic Adjuvants (Immunologic Adjuvant)IBA
12/2009 - 09/2007
2OligodeoxyribonucleotidesIBA
02/2009 - 07/2003
2montanide ISA 51IBA
07/2007 - 08/2006
2PAX3 Transcription FactorIBA
07/2006 - 06/2005
2HLA-DR9 antigenIBA
05/2005 - 10/2004
1Combined VaccinesIBA
12/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2021
1MHC class II transactivator proteinIBA
12/2021
1Immunologic Factors (Immunomodulators)IBA
11/2020
1Pathogen-Associated Molecular Pattern MoleculesIBA
11/2020
1Carboxymethylcellulose Sodium (Polycell)FDA Link
01/2020
1Zoledronic Acid (Zometa)FDA Link
01/2020
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2019
1interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA
12/2018
1Fetal Proteins (Fetoprotein)IBA
01/2018
1Toll-Like Receptor 3IBA
01/2018
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2018
1Transcription Factors (Transcription Factor)IBA
01/2018
1Aligeron (AS 2)IBA
01/2018
1Peptide TIBA
08/2017
12',5'-Oligoadenylate Synthetase (2',5' Oligoadenylate Synthetase)IBA
06/2017

Therapy/Procedure

53Immunotherapy
12/2021 - 08/2002
30Therapeutics
11/2020 - 06/2003
7Drug Therapy (Chemotherapy)
01/2018 - 10/2004